期刊文献+

Glycodelin在子宫内膜癌和子宫颈癌的表达 被引量:1

The study of Glycodelin expression in endometrial carcinoma and cervical cancer
下载PDF
导出
摘要  目的:探讨免疫抑制性糖蛋白(Glycodelin)在子宫内膜癌及子宫颈癌的表达。方法:采用免疫组织化学S-P法检测Glycodelin在30例子宫内膜癌及20例子宫颈癌组织中的表达,并评价其与临床病理分期和组织学分级的关系。结果:Glycodelin在子宫内膜癌、子宫颈鳞癌和子宫颈腺癌的表达率分别为73%(22/30)、53 33%(8/15)和60%(3/5),3组之间无统计学差异(P>0 05)。各临床病理分期的阳性率(子宫内膜癌:I期75%,II期75 00%,III期50%;子宫颈癌:Ia60%,Ib44 44%,IIa66 66%)无统计学差异(P>0 05)。各组织学分级的阳性率(子宫内膜癌:G170%,G277 78%和G366 67%;子宫颈癌:G159 14%,G250 00%和G360 00%)无统计学差异,P>0 05。结论:Glycodelin在子宫内膜腺癌和子宫颈癌均有表达,其表达与临床病理分期和组织学分级无明显关系。 Aim: To study the expression of immunosuppressive glycoprotein Glycodelin in endometrial carcinoma and cervical cancer. Methods: Immunohistochemical S-P assay was used to detect the expression of Glycodelin in paraffin-embedded sections of 30 cases of endometrial carcinoma and 20 cases of cervical cancer. The relationship between Glycodelin expression and clinicopathological characteristics was evaluated. Results: The positive immunostaining rate of Glycodelin in endometrial carcinoma, squamous cell carcinoma of the cervix and adenocarcinoma of the cervix was 73%(22/30), 53.33%(8/15) and 60%(3/5), respectively; there were no significant difference between each group, P>0.05. There were no significant differences between each clinicopathological stage(in endometrial carcinoma: stage I 75.00%, stage II 75.00% and stage III 50%;in cervical cancer:stage Ia 60%,stage Ib 44.44% and stage IIa 66.66%),P>0.05. No significant differences between each histological grade were found (in endometrial carcinoma: G_1 70%, G_2 77.78% and G_3 66.67%;in cervical cancer:G_1 59.14%,G_2 50.00% and G_3 60.00%),P>0.05. Conclusion:Glycodelin is expressed in endometrial carcinoma and cervical cancer,its expression is not correlated with clinicopathological staging or histological grade.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 2004年第2期185-189,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 广东省医学科研课题项目(A2003387)
关键词 免疫抑制性糖蛋白 子宫内膜癌 子宫颈癌 免疫组化 Glycodelin endometrial carcinoma cervical cancer immunohistochemistry
  • 相关文献

参考文献10

  • 1JULKUNEN M,RUTANEN E M,KOSKIMIES A,et al. Distribution of placental protein 14 in tissues and body fluids during pregnancy [J]. Br J Obstet Gynaecol,1985,92: 1145-1151.
  • 2HOROWITZ I R,CHO C H,SONG M Q,et al. Increased glycodelin levels in gynecological malignancies [J]. Int Gynecol Cancer,2001,11: 173-179.
  • 3BOJN H,KRAUS W,WINCKLER W. New soluble placental tissue proteins: their isolation,characterization,localization and quantification [J]. Placenta Suppl,1982,4: 67-81.
  • 4DELL A,MORRIS H R,EASTON R L,et al. Structural analysis of the oligosaccharides derived from glycodelin,a human glycoprotein with potent immunosuppressive and contraceptive activities [J]. J Biol Chem,1995,270: 24116-24126.
  • 5RACHMILEWITZ J,RIELY G J,TYKOCINSKI M L. Placental protein 14 functions as a direct T-cell inhibitor [J]. Cell Immunol,1999,191: 26-33.
  • 6MUKHOPADYAY D,SUNDERESHAN S,RAO C,et al. Placental protein 14 induces apoptosis in T cells but not in monocytes [J]. J Biol Chem,2001,276 (30): 28268-28273.
  • 7SONG M,RAMASWAMY S,RAMACHANDRAN S,et al. Angiogenic role for glycodelin in tumorigensis [J]. PNAS,2001,98: 9265-9270.
  • 8SEPPALA M,TAYLOR R N,KOISTINEN H,et al. Glycodelin: A major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation [J]. Endocrine Review,2002,23(4): 401-430.
  • 9MADELIN E,LASSUS H,SEPPALA M,et al. Glycodelin in ovarian serous carcinoma: association with differentiation and survival [J]. Cancer Res,2003,63: 6258-6264.
  • 10CONNOR J P,BRUDNEY A,FERRER K,et al. Glycodelin-A expression in the uterine cervix [J]. Gynecol Oncol,2000,79(2): 216-219.

同被引文献19

  • 1刘红梅,邢福祺,陈士岭.glycodelin在子宫内膜组织中的分泌特点及其与生殖活动的关系[J].中华妇产科杂志,2006,41(11):783-784. 被引量:1
  • 2Jaffe RC, Ferguson - Gottschall SD, Gao W, et al. His- tone deacetylase inhibition and progesterone act synergisti- caUy to stimulate baboon glycodelin gene expression. J Mol Endocrinol, 2007, 38(3): 401 -407.
  • 3Jeschke U, Karsten U, Reimer T, et al. Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. J Perinat Med, 2005, 33 (3) : 212 -218.
  • 4Jeschke U, Richter DU, Reimer T, et al. Glycodelin A and differentation of first trimester trophoblast ceils in vitro. Arch Gynecol Obstet, 2005, 272(2) : 151 -159.
  • 5Mandelin E,Lassus H, Seppala M, et al. Glycodelin in o- varian serous carcinoma: association with differentiation and survival . Cancer Res, 2003, 63 (19) : 6258 - 6264.
  • 6Hayes EC, Dominguez CE, Voelkel S, et al. Effect of gly- codelin on the production of vascular endothelial growth fac- tor in cumulus cells. Fentil Steril, 2006, 85(5) : 1553 - 1556.
  • 7Kunert - Keil C, Wiehm eier E, Jeschke U, et al. Immu- nolocalization of glycodelin in the genital tract of rats. J Mol Histol, 2005, 36 (12) : 111 - 117.
  • 8Foth D, Romer T. Glycodelin serum levels in women with ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol, 2003 ,108(2) : 199-220.
  • 9Telina S, Kauppila A, RonnBerg L, et al. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Am J Obstet Gynecol, 2006 (178) : 866 -871.
  • 10Richter C, Baetje M, Bischof A, et al. Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients. Anticancer Res, 2007,27(4A) : 2023 -2025.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部